Alpha-1 antitrypsin deficiency is a genetic disorder caused by mutations in the SERPINA1 gene, leading to reduced levels or an abnormal form of the alpha-1 antitrypsin protein, which normally protects lung tissue from damage by the enzyme neutrophil elastase. The deficiency can lead to early-onset emphysema, particularly in people who smoke, and the abnormal protein can also accumulate inside liver cells and cause liver disease. Swedish physicians Carl-Bertil Laurell and Sten Eriksson first described the deficiency in 1963 after noticing its absence on a routine blood protein test.
Facts
Classification
ICD-10 ChapterIV: Endocrine, Nutritional and Metabolic Diseases 1 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) First Described Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter IVQuote, List of chapters, Chapter IV
Endocrine, nutritional and metabolic diseases
View the Source 2. World Health Organization: Noncommunicable diseases (fact sheet)
World Health OrganizationMain Types sectionQuote, Main Types section
The main types of NCDs are cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes.
View the Source 3. Wikipedia: Alpha-1 antitrypsin deficiency
Wikipedia- A1AD is due to a mutation in the SERPINA1 gene that results in not enough alpha-1 antitrypsin (A1AT).
Wikipedia: Alpha-1 Antitrypsin Deficiency, History section
A1AD was discovered in 1963 by Carl-Bertil Laurell at Lund University in Sweden.
Lead section, transmission-route statement
Alpha-1 antitrypsin deficiency (A1AD or AATD) is a genetic disorder that may result in lung disease or liver disease.
View the Source Wikidata: Alpha-1 Antitrypsin Deficiency
Wikidata Q622437, class allow-list match (w-wdresolver-0926)View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.